Bio-Techne
TECH • NASDAQ
Bio-Techne is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kim Kelderman, with a market cap of $9.3B.
Market Cap$9.3B
Employees3.1K
CEOKim Kelderman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
TEC
Bio-Techne FAQ
Common questions about Bio-Techne
Bio-Techne is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $316.1M.
Bio-Techne has approximately 3,050 employees.